Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu
about
Surveillance of gastric intestinal metaplasia for the prevention of gastric cancerHelicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric CancerDiagnosis and management of gastric dysplasiaHuangqi Jianzhong Tang for Treatment of Chronic Gastritis: A Systematic Review of Randomized Clinical TrialsHelicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillanceTowards curative therapy in gastric cancer: Faraway, so close!Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?Helicobacter pylori Antibody Titer and Gastric Cancer ScreeningCorrelation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancerThe stomach in health and diseaseNoncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and BiomarkersKyoto global consensus report on Helicobacter pylori gastritisGastric cancer: descriptive epidemiology, risk factors, screening, and preventionGastric cancer: prevention, screening and early diagnosisManagement of gastric polyps: an endoscopy-based approachRisk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisalGastric cáncer: Overview.Etiology and Prevention of Gastric CancerSeventh tumor-node-metastasis staging of gastric cancer: Five-year follow-upPerformance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative.Diagnosis and management of high risk group for gastric cancerGastric intestinal metaplasia is associated with gastric dysplasia but is inversely correlated with esophageal dysplasiaEvaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for gastric cancerQuality Assurance in Endoscopy: Which Parameters?Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradicationRisk factors for metachronous gastric carcinoma development after endoscopic resection of gastric dysplasia: Retrospective, single-center study.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusSerological assessment of gastric mucosal atrophy in gastric cancer.Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis.Screening for and surveillance of gastric cancer.Gastric ulcer patients are more susceptible to developing gastric cancer compared with concomitant gastric and duodenal ulcer patients.Detection of precancerous gastric lesions and gastric cancer through exhaled breath.Strategies for eliminating death from gastric cancer in JapanFlexible spectral imaging color enhancement plus probe-based confocal laser endomicroscopy for gastric intestinal metaplasia detection.Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factorsPrevention strategies for gastric cancer: a global perspectiveEndoscopic gastric cancer screening and surveillance in high-risk groups.Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.Differential expression of microRNAs in preneoplastic gastric mucosa.
P2860
Q24198037-D7D978D5-7D0E-4AC7-ADA2-41932BE3FA21Q26748588-5D5CBAFA-852A-4FA8-88A3-8D32341B3888Q26765128-1D9B0EA6-5E4B-4074-BAD1-55CCA16B2F7DQ26773115-1E8746FB-61E1-47F2-9B33-2E27148316C5Q26774447-D5F0F8CB-776E-4E70-8ED1-1CE48FD1D2BEQ26778029-573BCD9C-6F83-44A9-8729-5C1CB3AF731FQ26778331-235BB20D-1356-432F-8B63-FB596FD1FF38Q26780322-81482F00-7D3E-4C50-940E-48C715A4F0F8Q26783991-CD590C67-423F-43B9-A9D5-F4E6EF474314Q26784036-2E852DB4-442E-464C-A426-04C8CF985BC9Q26785700-36BE9F20-A5F3-4D33-B083-720DC2524BD0Q26799430-EF82AA1B-483E-42DF-ABA7-1DDFBA0A5D21Q26849435-DD45F5BA-A58C-401E-8BED-A423ADB8802AQ26860418-ED90D6EB-8881-4BF2-B436-CDE5015E690AQ26864650-61547E9E-5466-4025-9A8B-83161AED0121Q27021198-4CC69F86-E727-4D65-B325-0B50242FE12FQ27692548-973BCCFE-1A05-463C-A941-83C7A8636134Q28072819-98AF6934-205F-4BC4-97D0-21D28D928E38Q28079527-74FB6D6D-ADB5-46D0-B075-DC8429461F71Q28080253-6073E13C-E843-47FD-BB24-3909DD1E4CFEQ28084323-D6F5A99C-ED9F-42B8-8810-8EB69F83B408Q30253061-D5CE7C5B-191E-4E5A-88BA-4FDB128EBB82Q30397798-5B4B0AD8-5842-4E8E-99A5-D84A253AE9F5Q30800118-7156D797-17DD-4A78-800D-82860F1FF730Q33621793-CBC3C2A4-7E39-43DE-A134-0ECDC55AE248Q33843440-58EFFC54-AA01-4AEC-9BE8-1FE30E9AD931Q33911623-76146C81-8F48-4A3C-8817-99B769FB9174Q34067951-7EFB9194-A75B-4DA3-B782-9B5860139B1FQ34145097-E88BF266-464B-47EB-99BF-82B2F0CE6638Q34305478-BBE05349-1060-4109-861D-065620DC3C98Q34326563-901DA92E-BBD0-4B8B-96AC-9B4020CE3689Q34427454-50EBB39C-E164-45AC-88A9-81F67112C43CQ34471484-5EE95F5D-1D64-4401-9CF6-B68C4E621A35Q34544931-36C02B37-D691-4A58-B1E5-26365E813DB1Q34595496-DF6C140F-22AB-4BDA-ABED-BCC785F4FDB7Q34639819-CD780913-6369-41DA-AD2B-75150AB77A83Q34658645-9F1A2B22-D449-4CFF-B327-10A2E26DF2CDQ34658657-3BC5D389-8558-498A-803B-16C7025ECB58Q34750616-B27C1F6A-3DCF-428E-B625-5DB886874145Q35051063-7D48811F-1B89-4632-94DD-ABD211C532BE
P2860
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Management of precancerous con ...... (ESP), and the Sociedade Portu
@ast
Management of precancerous con ...... (ESP), and the Sociedade Portu
@en
type
label
Management of precancerous con ...... (ESP), and the Sociedade Portu
@ast
Management of precancerous con ...... (ESP), and the Sociedade Portu
@en
prefLabel
Management of precancerous con ...... (ESP), and the Sociedade Portu
@ast
Management of precancerous con ...... (ESP), and the Sociedade Portu
@en
P2093
P2860
P50
P356
P1433
P1476
Management of precancerous con ...... (ESP), and the Sociedade Portu
@en
P2093
A C de Vries
A O'Connor
A Ristimaki
B Rembacken
C O'Morain
E J Kuipers
European Helicobacter Study Group
European Society of Gastrointestinal Endoscopy
European Society of Pathology
P2860
P356
10.1055/S-0031-1291491
P50
P577
2011-12-23T00:00:00Z